On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hubei University of Science and Technology

InstitutionResearch output, impact & collaborations

Hubei University of Science and Technology is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hubei University of Science and Technology?

ScholarIQrecord summary

Hubei University of Science and Technology is a research organisation in Xianning, CN. OpenAlex records 7,203 works and 179,822 citations for it. 2,381 researchers list it as their most recent affiliation.

How many works does Hubei University of Science and Technology have?

ScholarIQindexed works

Hubei University of Science and Technology has 7,203 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hubei University of Science and Technology have?

ScholarIQcitation count

Hubei University of Science and Technology has 179,822 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hubei University of Science and Technology?

ScholarIQresearcher count

Hubei University of Science and Technology has 2,381 researchers in the ScholarIQ index.

What is the average h-index at Hubei University of Science and Technology?

ScholarIQavg h-index

Hubei University of Science and Technology has an average h-index of 26 in OpenAlex.

What is the ROR of Hubei University of Science and Technology?

ScholarIQror

The ROR for Hubei University of Science and Technology is on the source record.

What is the OpenAlex record for Hubei University of Science and Technology?

ScholarIQopenalex

The OpenAlex for Hubei University of Science and Technology is on the source record.

Who are the most-cited researchers behind Hubei University of Science and Technology?

ScholarIQtop researchers by citations
1
Yan Song · Renal cell carcinoma treatment
206 works2,451 citations

What are the most-cited papers on Hubei University of Science and Technology?

ScholarIQmost cited works
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Yan Song, M. Kay Washington, Howard C. Crawford
Cancer Research. 2010260 CitationsOPEN ACCESS
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
Jing Huang, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Yan Song, Jie He
Cancer Medicine. 2021117 CitationsOPEN ACCESS
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Aiping Zhou, Yuxian Bai, Yan Song, Hong Luo, Xiu-Bao Ren, Xiuwen Wang, Benkang Shi, Cheng Fu, Ying Cheng, Jiyan Liu, Shukui Qin, Jun Li, Hanzhong Li, Xianzhong Bai, Dingwei Ye, Jinwan Wang, Jianhui Ma
The Oncologist. 2019115 CitationsOPEN ACCESS
PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance
Nilotpal Roy, Kenneth K. Takeuchi, Jeanine Ruggeri, Peter J. Bailey, David K. Chang, Joey H. Li, Laura Leonhardt, Sapna Puri, Megan T. Hoffman, Shan Gao, Christopher J. Halbrook, Yan Song, Mats Ljungman, Shivani Malik, Christopher V.E. Wright, David W. Dawson, Andrew V. Biankin, Matthias Hebrok, Howard C. Crawford
Genes & Development. 2016105 CitationsOPEN ACCESS
What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China
Puyuan Xing, Yixiang Zhu, Le Wang, Zhouguang Hui, Shangmei Liu, Jiansong Ren, Ye Zhang, Yan Song, Chengcheng Liu, Yunchao Huang, Xianzhen Liao, Xiaojing Xing, Debin Wang, Li Yang, Lingbin Du, Yu‐Qin Liu, Yongzhen Zhang, Yun‐Yong Liu, Donghua Wei, Kai Zhang, Jufang Shi, You‐Lin Qiao, Wanqing Chen, Junling Li, Min Dai, the LuCCRES Group
Cancer Medicine. 201980 CitationsOPEN ACCESS

How much of the research on Hubei University of Science and Technology is open access?

ScholarIQopen access share
91%OPEN ACCESS
Gold
55%
Green
9%
Hybrid
9%
Bronze
18%
Closed
9%

Related on ScholarIQ

470M+ articles · 14-day free trial